Human Hibernation

Four states are routinely called the same thing and are not. Torpor is a naturally occurring, reversible state of metabolic suppression. Synthetic torpor is an artificially induced, reversible hypometabolic state. Hibernation is multi-day torpor with periodic arousals. Therapeutic hypothermia is externally imposed cooling of a body that is still metabolising normally, and it is physiologically a different thing, because the body fights it. The distinction is not pedantry; it is the subject. In torpor the thermal set-point moves and the animal stops defending its temperature. In therapeutic hypothermia the set-point does not move, and everything the body does — shivering, vasoconstriction, catecholamine release — opposes the intervention.

The framing under test in this brief is the one the field is built on: if ground squirrels can do it, humans can be made to do it. The honest state of the record in 2026 is narrower than the framing and more interesting than its dismissal. Torpor-like states have been induced in rodents by at least five independent methods; one of them worked in a rat, a species with no torpor in its natural repertoire; the neural switch has been localised in the mouse hypothalamus; and no human being has ever been placed in a metabolically suppressed state by any of them.

Two facts organise everything that follows. First, the pharmacological result that generated the most excitement — hydrogen sulfide, Science, 2005 — produced no hypometabolism in sedated sheep in 2008 and no hypothermia or survival benefit in pigs in 2011, two published negatives almost never cited beside the original. Second, the clinical cousin of the technology, therapeutic hypothermia after cardiac arrest, went through a full cycle of adoption and partial retraction between 2002 and 2021 that the spaceflight literature almost never mentions. A brief that cites either as proof of concept is citing a literature that has moved against it.

Established The single most important result in this subject is that a non-hibernator can be driven into a torpor-like state, and it is twelve years old. Tupone, Madden and Morrison delivered N6-cyclohexyladenosine (CHA), an A1 adenosine receptor agonist, intracerebroventricularly — 5 uL at 1 mM — to rats held at 15 degC ambient. Core temperature fell from about 37 degC to a nadir of 26.7 degC (SD 0.9), a drop of roughly 10 degC, sustained across a six-hour exposure. Established Recovery was complete: normal behaviour, feeding and physiology within one to two days. Established The rat does not naturally enter torpor. If the programme were absent from non-hibernating mammals rather than merely unexpressed, central A1AR activation should not have produced it — and that inference is the load-bearing argument for the whole premise of this brief.

Established Torpor is a regulated state with an identifiable switch, not a failure of thermoregulation. Hrvatin and colleagues used activity-dependent labelling (FosTRAP) with DREADD chemogenetics to localise torpor control in the mouse to glutamatergic Adcyap1-positive neurons of the anterior ventromedial and lateral preoptic area (avMLPA) of the hypothalamus. Established Chemogenetic activation of that population drove body temperature as low as 20 degC with greatly reduced metabolic rate. Frontier This matters more than the temperature number: it converts “can we cool a human safely” into “can we address a specific neuron population,” a pharmacological problem rather than a thermodynamic one. Speculative It also implies the obvious next compound — an avMLPA-selective agonist rather than a broad A1AR agonist with cardiovascular side effects — and no such molecule could be found in the literature searched for this brief.

Frontier The first plausibly translatable induction method is non-invasive, and it is one paper from one laboratory. Yang, Yuan, Field and colleagues induced a torpor-like hypometabolic state in rodents with focused ultrasound aimed at the hypothalamic preoptic area: 3.2 MHz at 1.6 MPa peak negative pressure in mice, 1.5 MHz at 1.4 MPa in rats, 10-second pulses at 10 Hz with 30-second gaps. Established In mice the maximum core-temperature change was 3.26 degC (SE 0.19) downward, oxygen consumption fell 36.61% (SE 1.74), and heart rate fell 47.3%. Established Closed-loop feedback held mice at 32.95 degC (SD 0.45) for 24.90 hours (SD 0.63). Established In rats — again, a non-torpid species — the effect was about 2.5 times smaller: 1.33 degC (SE 0.22). Frontier Single-nucleus RNA sequencing implicated TRPM2 as the ultrasound-sensitive channel; knockdown suppressed the effect by 41.2%, leaving the majority of it unexplained.

Established The most important number in that paragraph is 36.61% against 3.26 degC. Oxygen consumption fell an order of magnitude further, proportionally, than temperature did. That is the best evidence available that suppression is not simply a consequence of the animal getting cold — the central objection to every rodent result, since a 25 g mouse cools and rewarms passively in a way a 70 kg human cannot. Frontier If suppression causes the temperature drop, surface-to-volume scaling is an engineering nuisance; if it follows it, the rodent literature is thermal inertia and transfers at no body size. Frontier Nobody has run the discriminating measurement — indirect calorimetry against core temperature at clamped ambient in a large mammal — and it is cheap.

Established The field's cleanest documented failure to scale is the one its enthusiasts cite least. Blackstone, Morrison and Roth reported in Science in 2005 that hydrogen sulfide induced a suspended-animation-like state in mice, and in 2007 that the state protected mice from lethal hypoxia. Both records were verified bibliographically for this brief; neither full text was obtained, so no metabolic figure from them is printed here. Established Then it failed twice, in two species, in two laboratories. Haouzi and colleagues published H2S induced hypometabolism in mice is missing in sedated sheep in 2008; Drabek, Kochanek, Stezoski and colleagues published Intravenous hydrogen sulfide does not induce hypothermia or improve survival from hemorrhagic shock in pigs in 2011. Established In both cases the title is the finding. Frontier Any argument that human torpor is near-term has to say why the next method will cross a boundary this one did not.

Established The clinical cousin was adopted on 275 patients and partly reversed on 1,861. The 2002 HACA trial randomised 275 patients after out-of-hospital cardiac arrest — 137 to bladder-temperature targets of 32 to 34 degC for a median 24 hours, 138 to normothermia. Favourable neurologic outcome at six months was 55% against 39%, RR 1.40 (95% CI 1.08 to 1.81), p=0.009, NNT 6; mortality 41% against 55%, RR 0.74 (95% CI 0.58 to 0.95), p=0.02, NNT 7. Established The limitations were recorded at the time and are large: unblinded, enrolment stopped when funding ended, and only 8% of assessed patients enrolled. Established TTM2, in 2021, randomised 1,900 and analysed 1,861 — 33 degC against actively targeted normothermia. Six-month all-cause mortality was 50% (465/925) against 48% (446/925), RR 1.04 (95% CI 0.94 to 1.14), p=0.37; poor functional outcome 55% against 55%, RR 1.00 (95% CI 0.92 to 1.09); and there was a harm signal, arrhythmia with haemodynamic instability 24% against 16%, RR 1.45 (95% CI 1.21 to 1.75), p<0.001. Established No benefit appeared in any prespecified subgroup, at 6.8 times the sample size of the trial that created the practice. Most guidelines now specify active normothermia, not cooling.

Established The outer bound of demonstrated human cold tolerance is a single case. Anna Bagenholm was resuscitated from accidental hypothermia at a core temperature of 13.7 degC with no heartbeat from 19:40 to 22:15 — two hours thirty-five minutes of circulatory arrest — rewarmed on cardiopulmonary bypass, and recovered nearly fully after an initial paralysis, with residual nerve injury in hands and feet. Frontier The Lancet case report itself could not be retrieved for this brief; the figures come from a secondary source citing it directly. Speculative The case is routinely offered as proof that deep human hypothermia is survivable. What it shows is that uncontrolled cooling in a young, healthy person, followed by extracorporeal rewarming, can be survived once. It is a bound, not a method.

Established A human trial of profound hypothermic preservation exists, and its published outcome is not what the coverage said. The EPR-CAT protocol induces profound hypothermia to about 10 degC by aortic flush in trauma patients in cardiac arrest who have failed conventional resuscitation, then attempts delayed resuscitation on cardiopulmonary bypass. Established The Department of Defense annual progress report of September 2019 records 5 EPR subjects and 5 controls enrolled and states plainly: “None of these subjects have survived.” Frontier In November 2019 press coverage reported that suspended animation had been successfully tried on a human for the first time. What had happened was that a preservation procedure had been performed; no published outcome supports the word successfully. Frontier No completed trial report could be located for this brief, so the correct status is unresolved rather than failed — but the burden of proof sits with anyone claiming a survivor.

Frontier One primate hibernates, and it is the strongest reason to think the programme is not gone from our lineage. The fat-tailed dwarf lemur of western Madagascar (Cheirogaleus medius) hibernates for months in tree holes, and in poorly insulated hollows its body temperature tracks ambient across a wide daily range rather than being defended — the first hibernator described in a tropical primate, reported by Dausmann and colleagues in Nature in 2004, with later work at the Duke Lemur Center on torpor in captive animals. Frontier Neither primary source was obtained for this brief, so no figure from them is printed and the case is carried as a named result rather than a measured one. Speculative Its value is structural: deep torpor exists inside the primate order, and a capability present in a primate is one whose machinery a human genome plausibly still contains in suppressed form. Speculative What it does not establish is that the machinery is reachable in a 70 kg obligate homeotherm with a brain taking a fifth of resting metabolism; the dwarf lemur weighs a few hundred grams.

Established The spaceflight case is a competent systems study resting on an unproven biological premise, and it names its own gaps. The SpaceWorks NASA Innovative Advanced Concepts Phase I study modelled a crew of six on a conjunction-class Mars mission — about 200 days out, 500 on the surface, 200 back. Established Habitat dry mass falls from 27.5 t for the DRA 5.0 TransHab baseline to 15.5 t in the baseline torpor case, a 44% reduction, and to 11.1 t in the more aggressive variant, 60%. Consumables fall from 13.1 t to 3.9 t, 71%. Initial mass in low Earth orbit falls 25% to 44%. Speculative The study claims this supports six crewed missions instead of three for the same budget. Established It also lists its own blockers: thromboembolism from prolonged intravenous access, catheter infection, electrolyte imbalance, coagulopathy, and hepatic and glycaemic complications of prolonged total parenteral nutrition at about 1.5 kg per person per day. Frontier Its stated state of the art is 14 days of therapeutic hypothermia in human patients — which is not torpor — and its conclusion, “no show-stoppers identified,” is a statement about the absence of a known blocker, not the presence of a demonstrated capability.

Established NASA's own scientists have published the gap in writing. A 2021 white paper from NASA Ames and Stanford argues for synthetic torpor principally as radioprotection — the driving risk being at least a 3% chance of an astronaut developing a fatal cancer on a Mars mission — and cites a hibernating-ground-squirrel dose-reduction factor of 1.4 against gamma radiation from a 1968 study, plus muscimol-induced torpor in rats showing reduced radiation toxicity in liver and testes. Established The document's entire argument is that the fundamental rodent investigations have not been done, and it proposes a sequence: mechanism, radioprotection at a space-radiation facility, omics, ISS and then deep-space rodent experiments, primates, then humans, “possibly beginning with critical care patients.” Established The 2025 Nature Metabolism review of the field states the position without qualification: there are no human clinical trials of synthetic torpor. That is the terminal position of section 2.

Frontier Duration is the axis nobody has attacked, and the gap is three orders of magnitude. The longest closed-loop synthetic torpor on record is about 24.9 hours, in a mouse. The longest continuous therapeutic hypothermia in humans cited by the NIAC study is 14 days, in critically ill patients whose metabolism was not suppressed. The Mars architecture requires 90 days to six months per transit. Established Nothing in the published literature bridges 25 hours to 90 days in any species, and no experiment currently under way is designed to. Frontier Duration is also where the complication list bites: thrombosis, catheter sepsis and hepatic dysfunction are week-scale problems, not day-scale ones, so the first 7-day and 30-day large-animal runs will generate the failure modes the field has never seen.

Frontier Ultrasonic induction is the most translatable method and the least replicated. It needs no transgene, no implanted cannula and no drug, and it worked in a species that does not naturally enter torpor. As of this writing it is one laboratory and one 2023 paper, with no independent replication located. Frontier The rat effect — 1.33 degC — is small enough that it may not survive transcranial delivery through a human skull, whose thickness, curvature and acoustic heterogeneity attenuate and defocus a beam far more than a rat's. Speculative A pig is the informative intermediate, because pig skull acoustics are the closest common laboratory analogue to human, and no pig experiment has been published.

Frontier Radioprotection is real at the tissue level and null at the endpoint that matters. In the best available heavy-ion experiment, rats made torpid with 5'-AMP monohydrate at 900 mg/kg intraperitoneally plus six hours at 16 degC immediately after irradiation with carbon ions at 290 MeV per nucleon showed fewer activated microglia, fewer apoptotic hepatocytes and less pulmonary proteinosis at 2 Gy. Established Survival at 8 Gy showed no significant difference, p=0.7767, with n=5 to 12 per group. Frontier The authors note that one animal's extended survival suggests the response may be much stronger in some individuals, which is a hypothesis about variance, not a result. Speculative A dose-reduction factor of 1.4, if it held in humans, removes about 29% of the dose — useful, and nowhere near a substitute for shielding.

Frontier The field's own review does not put spaceflight first. The 2025 Nature Metabolism review lists proposed medical applications in order: ischaemic protection in stroke and cardiac injury, organ preservation for transplant, radiation protection, lifespan extension, neuroprotection. Frontier The near-term case for synthetic torpor is clinical; the spaceflight case is the speculative extension that gets the coverage. Speculative That ordering also identifies the most likely first real market: not astronauts, but the transplant cold chain, where an extra few hours of viable ischaemic time changes organ allocation nationally.

Speculative The unasked question is whether memory survives torpor. Hibernating mammals undergo massive synaptic pruning and tau hyperphosphorylation during torpor bouts, reversed on arousal. A human cortex is far more dependent on continuously maintained synaptic state than a ground squirrel's. Speculative For human torpor to be acceptable, the pruning-and-restoration cycle would have to be information-preserving in a brain whose information is not stored the way a hibernator's is. Frontier This is answerable today, in rodents, for the price of a behavioural rig — memory retention across repeated induced torpor bouts in a species with testable long-term memory — and as far as this brief's research could establish, nobody is measuring it. It is the same question Brain Preservation asks from the opposite direction: whether structure is memory.

Speculative A persistent historical claim has no verifiable primary source. Plasma from hibernating ground squirrels was reported in the 1980s and 1990s to induce hibernation-like states in non-hibernators, with the active principle proposed to be a delta-opioid peptide — the “hibernation induction trigger,” usually associated with DADLE. Handwave The 2025 review still lists delta-opioid ligands among pharmacological induction routes, so the idea is alive in the field's own summaries. Handwave No primary source for the original experiments could be verified for this brief, and nothing quantitative about them is printed here. What would settle it is unglamorous: a purified factor with a dose-response curve in a large mammal. Until that exists, the claim should be treated as a named historical episode rather than a result.

Established The workback plan from a healthy adult held in suppressed metabolism for 90 to 180 days runs through nine links, and only one of them is a wall. In order: (1) show metabolic suppression is separable from cooling; (2) independently replicate ultrasonic induction, in rats and then in a pig; (3) produce more than 20% metabolic suppression in a pig or sheep sustained beyond 24 hours by any method; (4) extend duration from about 25 hours to 7 days, then 30; (5) show cognition and memory survive repeated bouts; (6) solve nutrition and waste at 90-plus days at a metabolic rate nobody has measured; (7) quantify radioprotection with a properly powered dose-response; (8) first human exposure under a critical-care indication; (9) healthy-volunteer torpor, reachable only after (8).

Frontier Link 3 is binding, and it is a scientific unknown with a documented failure record. Every other link is an engineering, clinical or governance problem of known shape — hard, expensive, but with a method. Link 3 has one serious attempt in the record and it failed twice: the compound that produced a Science paper and a decade of enthusiasm produced no hypometabolism in sedated sheep in 2008 and no hypothermia or survival benefit in pigs in 2011. Frontier Until some method crosses the mouse-to-large-mammal boundary, the spaceflight architecture is a competent mass study resting on an unproven premise, and its own authors write that the state of the art is 14 days of therapeutic hypothermia in sick humans.

Speculative Link 5 is not blocked by anything, and nobody is doing it. That is the more damning observation. Whether memory survives torpor is answerable in rodents now; it requires no new physics, no new drug and no primate. Its absence from the field's agenda is a fact about how the field is funded — radioprotection and mass budgets attract aerospace money, behavioural neuroscience of torpor attracts neither aerospace nor clinical money. Frontier Link 6 hides a similar assumption: the 1.5 kg per person per day parenteral nutrition figure is a resting-normothermic requirement, not a torpid measurement, and if metabolic rate falls by half the consumables case improves and the refeeding and hepatic risks worsen. Frontier Link 7 has a supply constraint as well as a scientific one — there are only a handful of heavy-ion beamlines in the world capable of the relevant dose-rate and ion species, and their time is allocated to radiotherapy and materials science.

Frontier This subject waits on results in three other fields and produces almost nothing they need. The first is hibernator cold-tolerance biology: cold-inducible RNA-binding proteins, membrane lipid remodelling, and mitochondrial suppression are what let a ground squirrel hold tissue at 5 degC without ischaemia-reperfusion injury on rewarming. Speculative If those mechanisms are inducible in human tissue, human torpor becomes a pharmacology problem; if they are not, deep human cooling remains an injury to be limited rather than a state to be entered.

Frontier The second is organ-scale cold tolerance and volumetric rewarming, which this brief shares with two neighbours. The strongest result in that literature is vitrification with nanoparticle-mediated rewarming of a rat kidney, transplanted and life-sustaining. Established It is a roughly 1 g organ, and the rewarming problem scales badly with volume. Frontier Cryonics needs this capability at whole-body scale, Brain Preservation needs it for whole-brain perfusion, and human hibernation would supply it if hibernator biology proved transferable. The three briefs share one technical bottleneck and the shared solution is more likely to come from transplant medicine than from any of them.

Frontier The third is large-animal metabolic phenotyping, which sounds like infrastructure and is the actual gate. Indirect calorimetry at clamped ambient in a 50 to 100 kg animal, with continuous core and peripheral temperature, is not exotic equipment; it is simply not deployed on this question anywhere. Speculative Adjacent to all three: primate neuroscience capable of chemogenetic or ultrasonic preoptic stimulation with calorimetry, which exists technically and has not been pointed at torpor.

Frontier Two dependencies are usually listed and are not real. Better spacecraft shielding and better propulsion would each reduce the case for torpor rather than enable it, so they are competitors, not inputs. Speculative What this brief genuinely needs from outside biology is narrower and duller: a continuous, non-invasive readout of whole-body metabolic rate that works on a sedated large animal and later on a patient. Frontier Without it there is no controlled variable, no dose, and no way to state what depth of suppression a protocol achieved — which is why so much of the literature reports temperature, a proxy, as though it were the state.

Established Experiment one, and it is cheap. Indirect calorimetry against core temperature at clamped ambient in a large mammal, under ultrasonic or A1AR induction, with the prediction stated in advance: if metabolic rate falls proportionally further than temperature, as it did in mice at 36.61% oxygen consumption against 3.26 degC, suppression is causal and body size is an engineering problem. Frontier If the two fall together, the rodent literature is thermal inertia and the field should say so.

Frontier Experiment two: independent replication of ultrasonic induction, first in rats at the published parameters, then transcranially in a pig, where skull acoustics approximate human. A negative in the pig would be the most informative single result available today. Frontier Experiment three: any method, any mechanism, producing more than 20% metabolic suppression in a pig or sheep sustained beyond 24 hours. This is the wall; it does not matter which method breaks it.

Frontier Experiment four: duration escalation with prespecified complication endpoints — closed-loop maintenance in a large mammal at 7 days, then 30, with thrombosis, catheter infection, electrolyte derangement, coagulopathy and hepatic function registered in advance rather than discovered. Speculative Experiment five: memory retention across repeated torpor bouts in a species with testable long-term memory. Behavioural, cheap, decisive, and unfunded.

Frontier Experiment six: a properly powered dose-response survival study, torpid against active, at a heavy-ion facility. The existing study had n=5 to 12 and a null survival endpoint at 8 Gy; a study designed to detect a dose-reduction factor of 1.5 with adequate power is a different scale of animal commitment and a different beamline allocation. Speculative Experiment seven: preoptic stimulation in a non-human primate, chemogenetic or ultrasonic, with core temperature and indirect calorimetry. This is the measurement that would tell us whether the avMLPA circuit is functional in a primate, and it is the step the field's own institutional map says nobody is funding.

Frontier One experiment is comparative rather than interventional and would cost almost nothing. Sequence and phenotype the induction machinery across a hibernating primate, a non-hibernating primate and a human: if the avMLPA circuitry and its ligand systems are conserved and merely unexpressed, that is a direct answer to the question the whole field is arguing about indirectly. Speculative And one negative result should be pre-registered as informative. If ultrasonic induction fails transcranially in a pig at published parameters, the field should treat that as the answer to link 2 rather than as a tuning problem — the H2S line stayed alive for a decade after two large-animal negatives precisely because nobody agreed in advance what would count as a refutation.

Frontier The control problem is closed-loop and it has been demonstrated only in an animal that weighs 25 g. Holding a mouse at 32.95 degC for 24.9 hours with feedback is a genuine engineering result; holding a 70 kg human at a chosen depth of suppression for months requires a controlled variable nobody has defined. Speculative Core temperature is a proxy, not the state: the thing being controlled is metabolic rate, and there is no bedside instrument that reports it continuously. A depth-of-torpor index — the equivalent of a bispectral index for anaesthesia — is a prerequisite nobody has built.

Established The support systems are the part with a known shape and a known failure list. Prolonged intravenous access brings thromboembolism and catheter sepsis; extended cooling brings electrolyte imbalance and coagulopathy; prolonged total parenteral nutrition brings fatty liver, bile stasis and glucose dysregulation. Frontier The nutrition mass figure of about 1.5 kg per person per day is a resting-normothermic assumption carried into a torpid architecture, and it is one of the few numbers in the mass budget that a single large-animal experiment could correct in either direction.

Speculative Two vehicle-level requirements are usually skipped. Rewarming is a thermal-power problem, not a nursing problem: bringing six crew from suppressed metabolism to functional in a defined window requires stored energy and heat-exchange capacity sized for the worst case, which is an emergency arousal during a contingency, not a nominal one. Handwave And the SpaceWorks “Sentinel Protocol” — one crew member awake at all times, rotating — converts a biological system into a crew-scheduling system whose reliability requirement is that the sentinel never fails to wake the others. Nothing in the torpor literature bears on that at all.

Frontier The induction hardware is the least of it, which is why it gets the attention. A transcranial focused-ultrasound array capable of holding a preoptic target through a moving human skull is a known engineering object: comparable arrays are already in clinical use for thermal ablation, with imaging-based aberration correction. Speculative What has no precedent is running one continuously for months in a vehicle with a constrained power and thermal budget, on a target that shifts as the subject's tissue state changes, with no operator present for five of the six crew.

Frontier The nearest neighbour is transplant cold-chain engineering, and it is ahead. Vitrification with nanowarming has already produced a cryopreserved rat kidney that was rewarmed, transplanted and sustained life. That community has funding, an approved clinical indication to aim at, and a regulatory route; the torpor community has none of the three. Speculative If hibernator cold-tolerance biology becomes transferable, it will be transplant surgeons who deploy it first.

Established Extracorporeal circulation is the enabling clinical technology in every human case in this brief. Cardiopulmonary bypass rewarmed the 13.7 degC survivor; delayed resuscitation on bypass is the second half of the EPR-CAT protocol; and ECMO capability is what makes profound hypothermic preservation thinkable in a trauma bay at all. Frontier The growth of ECMO centres is therefore a better leading indicator for human torpor research than anything in the spaceflight literature.

Frontier Focused ultrasound neuromodulation and chemogenetics are the two toolkits doing the work. Both are advancing for reasons entirely unrelated to torpor — essential tremor, epilepsy, drug-resistant depression, circuit neuroscience — and torpor inherits their transducer arrays, targeting and safety envelopes for free. Speculative Within this map, the relevant neighbours are Human Adaptation for Space, which shares the radiation problem torpor is proposed to mitigate, Artificial Magnetospheres, which is the competing answer to the same problem, and Cryonics and Brain Preservation, which share the cold-tolerance bottleneck.

Frontier Anaesthesiology is the closest analogue nobody in the torpor literature borrows from properly. It is the one field that routinely takes a person to a reversible, monitored, drug-maintained state and returns them — and it developed depth-of-state monitoring, standardised reversal, and a safety culture built on registries of rare harms. Speculative A depth-of-torpor index, a defined reversal protocol and a complication registry are all imports from that discipline rather than inventions, and their absence is the clearest sign that human torpor is still a laboratory subject rather than a clinical one.

Frontier Two adjacent literatures set the honest expectation. Hypothermic circulatory arrest in cardiac surgery has decades of data on what a cold, low-flow human tolerates and for how long, and it is measured in tens of minutes at deep temperatures. Speculative Space radiation biology sets the other bound: whatever dose reduction torpor supplies has to be argued against passive shielding mass, which is heavy, boring and known to work.

Established The most consequential institutional fact in this subject is that the primate step is unfunded and NASA has said so in print. The 2021 NASA Ames white paper exists to argue that the fundamental rodent work has not been done. Its proposed sequence — mechanism, radioprotection, omics, ISS rodents, deep-space rodents, primates, humans — is a research programme nobody has commissioned. Frontier The agency's actual financial exposure is a NIAC Phase I study, which is a small, deliberately speculative early-concept award and not a development programme.

Frontier The funding shape is the diagnosis. Aerospace money buys mass-budget studies and radioprotection experiments; clinical money buys trials with a recognised indication; neither buys large-animal metabolic phenotyping or the behavioural neuroscience of torpor, which is why the two cheapest decisive experiments in this brief are the two nobody is running. Speculative The organisational form that would fix it is unglamorous — a standing large-animal torpor facility with calorimetry and 30-day holding capability, jointly commissioned by a space agency and a critical-care research council — and no such institution exists in any country.

Frontier The European side of the record could not be verified for this brief and is named rather than cited. A European Space Agency topical team on hibernation for deep-space missions is repeatedly referenced in secondary coverage, with an associated review linking biology to engineering. The bibliographic record for that paper could not be confirmed during this brief's research, so no figure or conclusion is attributed to it here. That absence is itself informative about the field's citation hygiene: the ESA work is cited far more often than it is read.

Established The only institution funding human-scale work is a defence trauma programme. EPR-CAT ran on a US Army Medical Research and Materiel Command award, under the ethical framework that applies to patients in cardiac arrest with expected mortality above 95%. Frontier That is not incidental: it is the only setting where a first-in-human exposure is defensible, which means the regulatory path to human torpor runs through trauma surgery and not through aerospace medicine, whatever the mission architectures assume.

Established The first humans in a suppressed metabolic state will not be able to consent, and that is a design feature of the only viable pathway. EPR-CAT enrols patients in cardiac arrest from trauma who have failed conventional resuscitation; consent is by exception, under the framework for emergency research, with community consultation in place of individual agreement. Frontier That is defensible when expected mortality without the intervention approaches certainty, and it is the reason a healthy astronaut cannot be first. Speculative It also creates a permanent asymmetry: everything learned about human torpor for a generation will be learned in people who were dying, in conditions nothing like a transit to Mars.

Frontier A torpid crew member is a person who cannot withdraw. Consent to a 180-day suppressed state is consent given once, at the start, covering a period during which the subject cannot reassess, object, or exercise any of the rights that make research consent meaningful. Speculative Anaesthesia has the same structure over hours; nothing in medicine has it over months. The Sentinel Protocol makes this concrete — the awake crew member holds decision-making authority over five people who cannot object — and no framework for that authority has been written.

Frontier The overclaiming has a cost that is not merely aesthetic. A field whose most visible public claims are “a human was successfully placed in suspended animation” and “torpor protects against space radiation” — one contradicted by the funder's own progress report, the other contradicted by the survival endpoint of the study it rests on — is spending credibility it will need when it asks a research ethics committee to approve a 30-day large-animal protocol or a first elective human exposure. Speculative The correction is cheap and available now: cite the negatives beside the positives.

Speculative A subtler question sits under the mission architecture. A crew suspended for the transit does not experience the transit, which changes what a mission is for the people who fly it and removes the confinement, monotony and interpersonal stress that behavioural health programmes currently exist to manage. Handwave Whether that is a benefit or a loss is not a scientific question, and it has been argued only in fiction; it will matter the first time a crew is asked to choose.

Speculative If it worked, the near-term effect would be clinical and unglamorous, and it would be large. Metabolic suppression as a routine capability turns the golden hour in trauma into a longer interval, extends the viable ischaemic window in stroke and myocardial infarction, and lengthens organ preservation times enough to change how transplant organs are allocated across a continent rather than a city. Frontier That is the application list the field's own review puts first, and it does not require months of torpor — hours would do.

Speculative The spaceflight effect is real and smaller than the slogan. A 25% to 44% reduction in initial mass in low Earth orbit is a serious architectural change; the claim that it doubles the number of crewed missions a fixed budget supports is the study's own, and it does not touch propulsion, power or shielding. Handwave The version that would actually change the shape of human expansion is the one nobody can support today: multi-month torpor with a radioprotective dose-reduction factor above two, which would let a crew cross deep space in a lighter, less shielded vehicle and arrive without the cumulative dose that currently caps mission duration.

Speculative The deepest implication is about time rather than mass. A species able to suspend a subset of its members safely acquires an option it has never had: to move people through intervals rather than across distances — interstellar transit, epidemic waiting, waiting out a therapy that does not exist yet. Handwave Every one of those uses depends on a capability whose longest demonstration is 24.9 hours in a mouse, and the honest civilizational statement is that the option is currently notional.

Speculative The failure branch has consequences too, and they are worth naming. If large mammals turn out to be genuinely refractory, the deep-space architectures that assume torpor lose a quarter to a half of their notional mass margin, and the radiation problem reverts entirely to shielding and mission duration. Frontier That is not a catastrophe — it is the assumption most current mission planning already makes — but it would end a line of argument that has shaped how long-duration missions are discussed for a decade on the strength of a rodent literature.

These horizons track published experiments and trial registrations, not mission plans:

• 10 yr: Frontier Expect independent replication of ultrasonic torpor induction, in rodents, and the first serious attempt in a large mammal — a pig, because of skull acoustics. Frontier Expect the separability question to be answered: metabolic rate against core temperature at clamped ambient in a 50 kg animal is a cheap experiment whose result reorganises the field either way. Speculative Expect a completed or abandoned EPR-CAT successor to appear in the record, resolving the November 2019 claim one way or the other. Frontier Expect no human synthetic torpor, and expect duration in large animals to remain below one week.
• 25 yr: Speculative If link 3 falls — more than 20% metabolic suppression sustained beyond a day in a pig or sheep — the plausible sequence is duration escalation to 30 days, a defined depth-of-torpor instrument, and a first elective human exposure under a critical-care indication rather than an aerospace one. Speculative If link 3 does not fall in this window, the correct inference is not that the field is slow but that the mouse results do not transfer, and the honest response is to reclassify human torpor with the propositions that are probably false. Frontier Independent of either, expect hibernator-derived cold-tolerance biology to reach transplant medicine first, because that community has an indication, a reimbursement path and a trial pipeline.
• 50 yr: Speculative A capability of weeks-scale suppressed metabolism in humans, if it exists at all by then, will have arrived through critical care and organ preservation, not through spaceflight, and it will be measured in ICU days rather than transit months. Speculative The spaceflight application requires 90 to 180 days, which is a further order of magnitude beyond any clinically motivated endpoint, and no clinical funder will pay for it — that step needs the cross-disciplinary funding this brief's technology tree names as its binding external constraint. Handwave A serious radioprotective dose-reduction factor above two, sustained over months, remains unsupported by anything in the current record.
• 100 / 250+ yr: Handwave At this horizon the interesting question is whether metabolic time-shifting becomes an ordinary human option — elective suspension across an interstellar transit, or across a wait for a therapy that does not exist yet — and nothing in the current literature constrains the answer. Handwave The alternative terminal state is equally consistent with the evidence: that obligate homeothermy in a large-brained, poorly insulated primate is not a suppressible property, that every method crosses the mouse-to-large-mammal boundary and fails, and that the subject is remembered as a well-argued proposition that turned out to be false. Speculative On the record as it stands, neither branch can be excluded, and the discriminating experiment is affordable today.

• Depends on Nothing on this map produces the result this brief waits on. The binding link is a scientific unknown — whether any induction method produces sustained metabolic suppression in a large mammal — and no other brief is positioned to produce it, so no typed depends-on edge is claimed. The nearest thing to a supplier is transplant cryobiology, whose organ-scale cold-tolerance and volumetric-rewarming work is discussed under Cryonics and Brain Preservation, but that is a shared bottleneck rather than a dependency: all three briefs are waiting on the same biology and none of them is producing it for the others.
• Requires (not on this map) The constraint is a funding shape, not a discovery. The two decisive experiments in this brief are cheap — large-animal calorimetry against core temperature at clamped ambient, and memory retention across repeated torpor bouts in rodents — and neither has a natural funder, because aerospace budgets buy mass studies and radioprotection endpoints while clinical budgets buy trials against recognised indications, and these experiments are neither. The result is a field whose flagship architecture study assumes 90 to 180 days of human torpor while its own state-of-the-art line reads 14 days of therapeutic hypothermia in sick patients, and whose sponsoring agency has published a white paper saying the fundamental rodent work has not been done. What would discharge the constraint is a standing large-animal torpor facility with indirect calorimetry and 30-day holding capability, jointly commissioned by a space agency and a critical-care research council, with a protocol that registers the complication list in advance. No such institution exists anywhere, and its absence — not any scientific obstacle — is why link 5 of the workback plan has been answerable for a decade and remains unanswered.
• Enables If sustained suppression in a large mammal is demonstrated, the first things enabled are clinical and not on this map — ischaemic protection, organ preservation, trauma preservation. Within the map, a demonstrated multi-month torpor capability changes the mass and consumables assumptions behind Human Adaptation for Space and the crew-radiation case that Artificial Magnetospheres addresses by a different route. No typed enabling edge is claimed, because each of those consequences is conditional on a result that does not exist, and a typed edge would assert a dependency that the record does not support.
• Adjacent Hibernation physiology and comparative endocrinology; focused ultrasound neuromodulation and chemogenetics, which supply the induction toolkits; critical care and extracorporeal circulation, which supply every human data point in this brief; space radiation biology; and transplant cryobiology. Within this map: Cryonics, Brain Preservation, Human Adaptation for Space, Artificial Magnetospheres and Longevity Therapies, which shares this cluster's habit of restating conditional results as unconditional ones.

Established “A human has already been put into suspended animation.” The claim comes from November 2019 press coverage of EPR-CAT. The funder's own annual progress report, dated September 2019, records 5 EPR subjects and 5 controls enrolled and states: “None of these subjects have survived.” A preservation procedure was performed on a human being for the first time; no published outcome supports the word successfully. Frontier The status is unresolved — no completed trial report could be located — which is a different and more interesting claim than either the enthusiast or the sceptical version.

Established “Hydrogen sulfide can put people into suspended animation.” The 2005 Science paper in mice is real and the follow-up protection result in mice is real. What is almost never cited beside them: H2S induced hypometabolism in mice is missing in sedated sheep (2008) and Intravenous hydrogen sulfide does not induce hypothermia or improve survival from hemorrhagic shock in pigs (2011). Established Two species, two laboratories, two negatives, both in the peer-reviewed record. Frontier Correcting this omission moves the estimate of how close human torpor is by more than any positive result of the last decade.

Established “Therapeutic hypothermia proves induced hypometabolism works in humans.” The 2002 trial that established the practice enrolled 275 patients, was unblinded, stopped when funding ran out, and enrolled 8% of those screened. TTM2, at 1,861 analysed, found six-month mortality RR 1.04 (95% CI 0.94 to 1.14), identical functional outcomes, and arrhythmia with haemodynamic instability at 24% against 16%, RR 1.45 (95% CI 1.21 to 1.75). Established Cooling a normothermic human is not torpor in any case: the set-point does not move and the body spends energy opposing the intervention. Frontier This is an error held on both sides. Enthusiasts cite therapeutic hypothermia as proof the clinical ground is prepared; sceptics cite TTM2 as proof induced hypometabolism failed. Both cite the wrong thing: the trial that failed was testing heat removal, not metabolic suppression.

Established “Torpor protects against space radiation.” The best available heavy-ion experiment found tissue-level protection at 2 Gy and no significant survival difference at 8 Gy, p=0.7767, with n=5 to 12 per group. The much-quoted protection figure from the hibernation literature is a dose-reduction factor of 1.4 from a 1968 ground-squirrel study, named in a NASA white paper and not obtained for this brief. Speculative A DRF of 1.4 does not solve the Mars radiation problem; it makes it about 29% smaller, leaving the shielding requirement in place.

Established “We can already keep people in torpor for two weeks.” The 14-day figure comes from the NIAC study and refers to therapeutic hypothermia in critically ill patients — externally imposed cooling of a normally metabolising body. The longest synthetic torpor on record is about 24.9 hours, in a mouse. Frontier The gap between those two numbers is not a detail; it is the subject.

Established “Bears hibernate, so hibernation is a mammalian capability we could switch on.” Bears do not enter deep torpor — their core temperature falls by only a few degrees, which is why they can rouse and give birth mid-winter. Deep hibernators are overwhelmingly small animals, and body-size scaling is the crux of the problem. Frontier The existence proof most often reached for is the one least like the thing proposed. Frontier The better one is the fat-tailed dwarf lemur, an obligate hibernating primate, carried here as a named result because the primary sources were not obtained — and it weighs a few hundred grams, which is where the analogy keeps failing.

Established “NASA is developing hibernation for Mars.” NASA funded a NIAC Phase I concept study — the agency's small, deliberately speculative early-concept programme — and NASA Ames researchers published a 2021 white paper whose thesis is that the fundamental rodent work has not been done. There is no development programme, no flight project and no line item. Frontier The same correction applies, less certainly, to the European side, where an ESA topical team is widely cited and its output could not be bibliographically verified here.

Established “The ultrasound torpor receptor has been found.” TRPM2 knockdown suppressed the effect by 41.2% — meaning most of the effect is unexplained — in a single-laboratory, unreplicated 2023 result. Frontier “A channel contributing about two-fifths of an unreplicated effect” is a fair description; “the receptor” is not.

Established “Torpor would save most of a Mars mission's mass.” The study's own numbers are specific and more modest than the slogan: habitat dry mass down 44% in the baseline case, consumables down 71%, initial mass in low Earth orbit down 25% to 44%. Established Propulsion, power and shielding are untouched. Frontier The claim that this doubles the number of crewed missions a fixed budget supports is the study's own cost modelling, from a contractor proposing the concept, and should be read as such.

Frontier The steelman of the position that human hibernation is simply impossible, stated at full strength. Humans are large, poorly insulated obligate homeotherms with a brain consuming about 20% of resting metabolism and no seasonal torpor anywhere in the lineage. Every pharmacological method that worked in a mouse has failed in a sheep or a pig. No human has ever been placed in a metabolically suppressed state. The closest clinical analogue failed its largest trial with a harm signal attached; the closest attempt at profound hypothermic preservation has produced no published survivor; and the longest synthetic torpor on record is about 25 hours, in an animal weighing 25 g. Frontier On the current record this is not obviously wrong. Frontier The answer is three results and no more: central A1AR activation drove a rat to 26.7 degC with full recovery; ultrasound did something similar non-invasively in the same species; and in mice oxygen consumption fell an order of magnitude further than temperature. Speculative That is enough to justify the large-animal experiment and not enough to justify a mission architecture, and the field's central error is treating it as the second thing.

Handwave The exotic end, labelled as such. Multi-month synthetic torpor in a healthy adult, metabolic reduction as a primary radiation countermeasure, elective suspension across an interstellar transit, and pharmacological reactivation of a programme a human lineage never expressed: each has a coherent mechanism sketch and an advocate, and not one has an experiment behind it in a mammal above 25 kg. Handwave That is not a reason to leave them off a research agenda. It is a reason to write them down with the flag attached, next to the sentence that makes them tractable: the measurement that would move any of them from handwave to frontier is a calorimetry run in a pig, and it has not been done.